1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10830)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22056)
  2. Department of Medicine (22034)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5183)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22056)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase Ib/II trial of tisotumab vedotin (TV) +/- bevacizumab (BEV), pembrolizumab (PEM), or carboplatin (CBP) in recurrent or metastatic cervical cancer (innovaTV 205/ENGOT-cx8/GOG-3024)
    Meeting Abstract

    Vergote, I.; Concin, N.; Mirza, M. R.; Andreassen, C. M.; Lorusso, D.; Gennigens, C. N.; Banerjee, S. N.; O'Cearbhaill, R. E.; Campos, S.; Nicacio, L. V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • SIENDO/ENGOT-EN5: A randomized phase III trial of maintenance with selinexor/placebo after combination chemotherapy in patients with advanced or recurrent endometrial cancer
    Meeting Abstract

    Vergote, I.; Hamilton, E. P.; Romero, I.; Guerra, E. M.; Buscema, J.; Laenen, A.; Perri, T.; Estevez-Garcia, P.; Raposo, C. G.; Levy, T.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase II study of siG12D-LODER in combination with chemotherapy in patients with locally advanced pancreatic cancer (PROTACT)
    Meeting Abstract

    Varghese, A. M.; Ang, C.; Dimaio, C. J.; Javle, M. M.; Gutierrez, M.; Yarom, N.; Stemmer, S. M.; Golan, T.; Geva, R.; Semenisty, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase Ia/Ib, dose-escalation/expansion study of BI 907828 in combination with BI 754091 and BI 754111 in patients (pts) with advanced solid tumors
    Meeting Abstract

    Tolcher, A. W.; Hafez, N.; Yamamoto, N.; Park, J.; Grempler, R.; Lucarelli, A. G.; Lahmar, M.; Wang, B. S.; Gounder, M. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase II randomized study of telaglenastat, a glutaminase (GLS) inhibitor, versus placebo, in combination with pembrolizumab (Pembro) and chemotherapy as first-line treatment for KEAP1/NRF2-mutated non-squamous metastatic non-small cell lung cancer (mNSCLC)
    Meeting Abstract

    Skoulidis, F.; Neal, J. W.; Akerley, W. L.; Paik, P. K.; Papagiannakopoulos, T.; Reckamp, K. L.; Riess, J. W.; Jenkins, Y.; Holland, S.; Parlati, F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • High correlation between TMB, expressed TMB, and neoantigen load using tumor: Normal whole exome DNA and matched whole transcriptome RNA sequencing
    Meeting Abstract

    Szeto, C.; Gounder, M. M.; Parulkar, R.; Nguyen, A.; Rabizadeh, S.; Reddy, S. K.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Decision aids for localized prostate cancer: Initial outcomes from NCI Community Oncology Research Program Alliance Research Base Cancer Care Delivery Research (CCDR) Protocol-A191402CD: A cluster-randomized trial
    Meeting Abstract

    Tilburt, J. C.; Pacyna, J. E.; Petereit, D. G.; Kaur, J. S.; Rapkin, B. D.; Grubb, R.; Chang, G. J.; Morris, M. J.; Kovac, E.; Sloan, J. A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • POLO: Radiologic assessment of the impact of maintenance olaparib in patients (pts) with metastatic pancreatic cancer (mPaC)
    Meeting Abstract

    Schwartz, L. H.; Kindler, H. L.; Hammel, P.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase II basket study of MCLA-128, a bispecific antibody targeting the HER3 pathway, in NRG1 fusion-positive advanced solid tumors
    Meeting Abstract

    Schram, A. M.; Drilon, A. E.; Macarulla, T.; O'Reilly, E. M.; Rodon, J.; Wolpin, B. M.; Ou, S. H. I.; Kim, D. W.; Yang, J. C.; Lam, J. Y. C.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase III study of first-line zolbetuximab plus CAPOX versus placebo plus CAPOX in Claudin 18.2(+)/HER2(-) advanced or metastatic gastric or gastroesophageal junction adenocarcinoma: GLOW
    Meeting Abstract

    Shah, M. A.; Ajani, J. A.; Al-Batran, S. E.; Bang, Y. J.; Catenacci, D.; Enzinger, P. C.; Ilson, D. H.; Kim, S.; Lordick, F.; Shitara, K.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save